Sickle Cell Anaemia in a Changing World
article has not abstract
Vyšlo v časopise:
Sickle Cell Anaemia in a Changing World. PLoS Med 10(7): e32767. doi:10.1371/journal.pmed.1001483
Kategorie:
Perspective
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001483
Souhrn
article has not abstract
Zdroje
1. OmranAR (1971) The epidemiologic transition: a theory of the epidemiology of population change. Milbank Mem Fund Q 49: 509–538.
2. OmranAR (1983) The epidemiologic transition theory. A preliminary update. J Trop Pediatr 29: 305–316.
3. SalomonJA, MurrayCJL (2002) The epidemiologic transition revisited: compositional models for causes of death by age and sex. Popul Dev Rev 28: 205–228.
4. World Health Organization (2013) World health statistics 2013. Geneva: World Health Organization.
5. PielFB, HaySI, GuptaS, WeatherallDJ, WilliamsTN (2013) Global Burden of Sickle Cell Anaemia in Children under Five, 2010–2050: Modelling Based on Demographics, Excess Mortality, and Interventions. PLoS Med 10: e1001484 doi:10.1371/journal.pmed.1001484
6. PielFB, PatilAP, HowesRE, NyangiriOA, GethingPW, et al. (2013) Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet 381: 142–151.
7. DarlisonMW, ModellB (2013) Sickle-cell disorders: limits of descriptive epidemiology. Lancet 381: 98–99.
8. CaldwellJC (1993) Health transition: the cultural, social and behavioural determinants of health in the third world. Soc Sci Med 36: 125–135.
9. FrenkJ, BobadillaJL, SepulvedaJ, Lopez CervantesM (1989) Health transition in middle-income countries: new challenges for health care. Health Policy Plan 4: 29–39.
10. Keeley J, Scoones I (1999) Understanding environmental policy processes: a review. Brighton (UK): Institute of Development Studies. Working Paper 89. 120 p.
11. Clay E, Schaffer B, editors (1986) Room for manoeuvre: an explanation of public policy in agriculture and rural development. London: Heinemann.
12. SmithKR, CorvalánC, KjellströmT (1999) How much global ill health is attributable to environmental factors? Epidemiology 10: 573–584.
13. ShiffmanJ (2010) Issue attention in global health: the case of newborn survival. Lancet 375: 2045–2049.
14. EdwinAK, EdwinF, EtwireV (2011) Controlling sickle cell disease in Ghana—ethics and options. Pan African Med J 10: 14–22.
15. McCavitTL (2012) Sickle cell disease. Pediatr Rev 33: 195–206.
16. AndersonM, AdnaniM (2013) “You just have to live with it”: coping with sickle cell disease in Jamaica. Qual Health Res 23: 655–664.
17. AygunB, OdameI (2012) A global perspective on sickle cell disease. Pediatr Blood Cancer 59: 386–390.
18. Fifty-ninth World Health Assembly (2006) Resolutions: WHA59.20—sickle cell anaemia. Geneva: World Health Organization. Available: http://apps.who.int/gb/ebwha/pdf_files/WHA59-REC1/e/Resolutions-en.pdf. Accessed 12 June 2013.
19. World Health Organization (2010) Sickle-cell disease: a strategy for the WHO African Region. AFR/RC60/8. Malabo: World Health Organization Regional Office for Africa.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2013 Číslo 7
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Co dělat při intoleranci statinů?
- Pleiotropní účinky statinů na kardiovaskulární systém
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
Najčítanejšie v tomto čísle
- Changes in Association between Previous Therapeutic Abortion and Preterm Birth in Scotland, 1980 to 2008: A Historical Cohort Study
- Multiplex Identification of Gram-Positive Bacteria and Resistance Determinants Directly from Positive Blood Culture Broths: Evaluation of an Automated Microarray-Based Nucleic Acid Test
- Combatting Substandard and Falsified Medicines: A View from Rwanda
- Reflections on the Global Burden of Disease 2010 Estimates